Halo nevus of the choroid in 150 patients: The 2010 Henry van Dyke lecture

Archives of Ophthalmology

Volumn 128, Issue 7, 2010, Pages 859-864

  Shields, Carol L ^a   Maktabi, Azza My ^a   Jahnle, Erica ^a   Mashayekhi, Arman ^a   Lally, Sara E ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ATROPHY; AUTOIMMUNE DISEASE; CHOROID; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIABETES MELLITUS; EPITHELIUM CELL; FEMALE; FOLLOW UP; HALO NEVUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RETINA EDEMA; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ACUITY; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHOROID NEOPLASMS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, HALO; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 77954971103     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.132     Document Type: Article

References (29)

1. Elder D, Elenitsas R. Halo nevus. In: Elder D, Elenitsas R, Jaworksy C, Johnson B, eds. Lever's Histopathology of the Skin. 8th ed. Philadelphia, PA: Lippincott-Raven Publishers; 1997:652-654.
2. Kopf AW, Morrill SD, Silberberg I. Broad spectrum of leukoderma acquisitum centrifugum. Arch Dermatol. 1965;92(1):14-33.
3. Rhodes A. Neoplasms: benign neoplasias, hyperplasias, and dysplasias of melanocytes. In: Fitzpatrick TB, Eisen A, Wolff K, Freedberg I, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill, Inc; 1987:877-918.
4. Fournier GA, Albert D, Wagoner MD. Choroidal halo nevus occurring in a patient with vitiligo. Surv Ophthalmol. 1984;28(6):671-672. (Pubitemid 14122952)
5. Chang MA, Fournier G, Koh HK, et al. Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma. Graefes Arch Clin Exp Ophthalmol. 1986;224(6):529-535.
6. Shields CL, Furuta M, Mashayekhi A, et al. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes. Ophthalmology. 2008;115(3):546-552.
7. Shields JA, Shields CL. Intraocular Tumors: An Atlas and Textbook . 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:63,67.
8. Prevalence and incidence of autoimmune diseases. Health Grades Inc Web site. http://www.wrongdiagnosis.com/a/ai/prevalence.htm. Accessed July 15, 2009.
9. Surveillance Epidemiology and End Results stat fact sheets: melanoma of the skin. National Cancer Institute Web site. http://seer.cancer.gov/statfacts/ html/melan.html. Accessed July 15, 2009.
10. National and state population estimates. United States Census Bureau Web site. http://www.census.gov/popest/states/NST-ann-est2006.html. Accessed July 15, 2009.
11. Shields CL, Shields JA, Kiratli H, De Potter P, Cater JR. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 1995;102(9):1351-1361.
12. Shields CL, Cater JC, Shields JA, Singh AD, Santos MC, Carvalho C. Combination of clinical factors predictive of growth of small choroidalmelanocytic tumors. Arch Ophthalmol. 2000;118(3):360-364. (Pubitemid 30152376)
13. Shields CL, Furuta M, Berman EL, et al. Choroidal nevus frequency of transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol. 2009;127(8):981-987.
14. Tokura Y, Yamanaka K, Wakita H, et al. Halo congenital nevus undergoing spontaneous regression: involvement of T-cell immunity in involution and presence of circulating anti-nevus IgM antibodies. Arch Dermatol. 1994;130(8):1036-1041.
15. Baranda L, Torres-Alvarez B, Moncada B, et al. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi. J Am Acad Dermatol. 1999;41(4):567-572.
16. Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol. 1997;37(4):620-624.
17. Bergman W, Willemze R, de Graaff-Reitsma C, Ruiter DJ. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. J Invest Dermatol. 1985;85(1):25-29. (Pubitemid 15069708)
18. Musette PH, Bachelez H, Flageul B, et al. Immune-mediated destruction of melanocytes in halo nevi is associated with local expansion of limited number of T cell clones. J Immunol. 1999;162(3):1789-1794.
19. Langer K, Konrad K. Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature. J Dermatol Surg Oncol. 1990;16(4):377-380. (Pubitemid 20159169)
20. Schmitt D, Ortonne JP, Haftek M, Thivolet J. Halo nevus and halo melanoma: immunocytochemical study of the inflammatory cell infiltrate. In: Ackerman AB, ed. Pathology of Malignant Melanoma. New York, NY: Masson; 1981:333-340.
21. Roenigk HH, Deodhar SD, Krebs JA, Barna B. Microcytotoxicity and serum blocking factors in malignant melanoma and halo nevus. Arch Dermatol. 1975;111(6):720-725.
22. Epstein WL, Sagebeil R, Spitler L, Wybran J, Reed WB, Blois MS. Halo nevi and melanoma. JAMA. 1973;225(4):373-377.
23. Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB. Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol. 1982;118(1):34-36.
24. Schrader WA, Helwig EB. Balloon cell nevi. Cancer. 1967;20(9):1502-1514.
25. Khalil MK. Balloon cell malignant melanoma of the choroid: ultrastructural studies. Br J Ophthalmol. 1983;67(9):579-584.
26. McGovern VJ. Spontaneous regression of melanoma. Pathology. 1975;7(2):91-99.
27. Jakobiec FA, Shields JA, Desjardins L, Iwamoto T. Balloon cell melanomas of the ciliary body. Arch Ophthalmol. 1979;97(9):1687-1692.
28. Shields JA, Annesley WH, Totino JA. Nonfluorescent malignant melanoma of the choroid diagnosed with the radioactive phosphorus uptake test. Am J Ophthalmol. 1975;79(4):634-640.
29. Rodrigues MM, Shields JA. Malignant melanoma of the choroid with balloon cells: a clinicopathologic study of three cases. Can J Ophthalmol. 1976;11(3):208-216.